SANUWAVE Health, Inc. (SNWV) Form 10-Q — May 12, 2026
SANUWAVE Health, Inc. reported a modest revenue growth of 3% to $9.6 million for the three months ended March 31, 2026, compared to $9.3 million in the same period of 2025. The increase was primarily driven by a 22% growth in the quantity of UltraMIST® disposables sold, despite a 6% decrease in the average selling price of disposables and an 11% decrease in the average selling price of UltraMIST® systems. The company's net loss for the three months ended March 31, 2026, was $1.4 million, a significant improvement from the $6.1 million net loss reported in the same period of 2025.
Key figures
- Eps Beat
- 0
- Revenue
- 9619
- Total Debt
- 20125
- Debt Amount
- 20125
- Revenue Yoy
- 3
- Total Assets
- 37097
- Cash Position
- 10779
- Deal Value Usd
- 0
- Interest Rate
- 4
- Maturity Date
- 2029
- Gross Proceeds
- 0
- Offering Price
- 0
- Shares Offered
- 0
- Shares Outstanding
- 8594209
- Adjusted EBITDA
- 1089
- State And Local Sales Tax
- 339
- Stock Based Compensation
- 1472
Price after filing
Close on the filing date to close N calendar days later (from $16.04). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.